Laboratory methods for monitoring argatroban in heparin‐induced thrombocytopenia

Diagnosis and management of heparin-induced thrombocytopenia

(2020) Yves Gruel et al.   Anaesthesia Critical Care & Pain Medicine

Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients

(2019) Jacob T. Beyer et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

More on the Limitations of the Activated Partial Thromboplastin Time for Monitoring Argatroban Therapy

(2017) Joost Van Veen et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Argatroban monitoring: aPTT versus chromogenic assay

(2016) Ngochong Vu et al.   AMERICAN JOURNAL OF HEMATOLOGY

Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban

(2016) Susan Guy et al.   BRITISH JOURNAL OF HAEMATOLOGY

Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban

(2015) S. Guy et al.   International Journal of Laboratory Hematology

Measuring Direct Thrombin Inhibitors With Routine and Dedicated Coagulation Assays

(2012) Joyce Curvers et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients

(2008) Robert Siegmund et al.   THROMBOSIS RESEARCH